Distinct Roles of Sphingosine Kinase 1 and 2 in Murine Collagen-Induced Arthritis
- 1 August 2009
- journal article
- research article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 183 (3), 2097-2103
- https://doi.org/10.4049/jimmunol.0804376
Abstract
Sphingosine kinase (SphK) phosphorylates sphingosine into sphingosine-1-phosphate (S1P). S1P plays a critical role in angiogenesis, inflammation, and various pathologic conditions. To date, two mammalian isoenzymes, SphK1 and SphK2, have been identified. Although both SphK1 and SphK2 share overall homology and produce the common product, S1P, it has been proposed they display different unique and separate functions. In this study, we examined the role of SphK1 and SphK2 in a murine collagen-induced arthritis model by down-regulating each isoenzyme via specific small interfering RNA (siRNA). Prophylactic i.p. administration of SphK1 siRNA significantly reduced the incidence, disease severity, and articular inflammation compared with control siRNA recipients. Treatment of SphK1 siRNA also down-regulated serum levels of S1P, IL-6, TNF-α, IFN-γ, and IgG2a anti-collagen Ab. Ex vivo analysis demonstrated significant suppression of collagen-specific proinflammatory/Th1 cytokine (IL-6, TNF-α, IFN-γ) release in SphK siRNA-treated mice. Interestingly, mice received with SphK2 siRNA develop more aggressive disease; higher serum levels of IL-6, TNF-α, and IFN-γ; and proinflammatory cytokine production to collagen in vitro when compared with control siRNA recipients. Together, these results demonstrate the distinct immunomodulatory roles of SphK1 and SphK2 in the development of inflammatory arthritis by regulating the release of proinflammatory cytokines and T cell responses. These findings raise the possibility that drugs which specifically target SphK1 activity may play a beneficial role in the treatment of inflammatory arthritis.This publication has 32 references indexed in Scilit:
- The alliance of sphingosine-1-phosphate and its receptors in immunityNature Reviews Immunology, 2008
- Principles of bioactive lipid signalling: lessons from sphingolipidsNature Reviews Molecular Cell Biology, 2008
- Sphingosine kinase signalling in immune cells: Potential as novel therapeutic targetsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2008
- Anaphylatoxin Signaling in Human NeutrophilsPublished by Elsevier BV ,2004
- Antisense Knockdown of Sphingosine Kinase 1 in Human Macrophages Inhibits C5a Receptor-Dependent Signal Transduction, Ca2+ Signals, Enzyme Release, Cytokine Production, and ChemotaxisThe Journal of Immunology, 2004
- Sphingosine-1-phosphate: an enigmatic signalling lipidNature Reviews Molecular Cell Biology, 2003
- Human sphingosine kinase: molecular cloning, functional characterization and tissue distributionGene, 2000
- Molecular Cloning and Functional Characterization of a Novel Mammalian Sphingosine Kinase Type 2 IsoformPublished by Elsevier BV ,2000
- Formyl Peptide Receptor Signaling in HL-60 Cells through Sphingosine KinasePublished by Elsevier BV ,1999
- Molecular Cloning and Functional Characterization of Murine Sphingosine KinasePublished by Elsevier BV ,1998